Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: An epidemiological analysis

Gynecologic Oncology

Volumn 123, Issue 3, 2011, Pages 456-460

  Vay, Agnieszka ^a   Kumar, Sanjeev ^b   Seward, Shelly ^a   Semaan, Assaad ^a   Schiffer, Charles A ^c   Munkarah, Adnan R ^a,d   Morris, Robert T ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Epidemiology; Epithelial ovarian carcinoma; t AML

Indexed keywords

CYCLOPHOSPHAMIDE; PACLITAXEL;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CHRONIC GRANULOCYTIC LEUKEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SAFETY; EPITHELIAL OVARIAN CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; NATIONAL HEALTH ORGANIZATION; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; FEMALE; HUMANS; LEUKEMIA, MYELOID; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 81155133887     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.07.097     Document Type: Article

References (15)

1. L.A. Godley, and R.A. Larson Therapy-related myeloid leukemia Semin Oncol 35 4 2008 418 429
2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics 2009 CA Cancer J Clin 59 4 2009 225 249
3. R.F. Ozols Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease and new agents J Natl Compr Canc Netw 2 Suppl. 2 2004 S60 S73
4. P. Sabbatini Consolidation therapy in ovarian cancer: a clinical update Int J Gynecol Cancer 19 Suppl. 2 2009 S35 S39
5. D. Rund, S. Krichevsky, S. Bar-Cohen, N. Goldschimdt, M. Kedmi, and E. Malik Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients Leukemia 19 2005 1919 1928 (Pubitemid 41554000)
6. S.M. Smith, M.M. Le Beau, D. Huo, T. Karrison, R.M. Sobecks, and J. Anastasi Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series Blood 102 2003 43 52 (Pubitemid 36759634)
7. S. Yeasmin, K. Nakayama, M. Ishibashi, A. Oride, A. Katagiri, and I.N. Purwana Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel and carboplatin based chemotherapy in an ovarian cancer patient: a case report and literature review Int J Gynecol Cancer 18 6 2008 1371 1376
8. G. Colon-Otero, G.D. Malkasian, and J.H. Edmonson Secondary myelodysplasia and acute leukemia following carboplatin-containing combination chemotherapy for ovarian cancer J Natl Cancer Inst 85 22 1993 1858 1860 (Pubitemid 23333621)
9. L.B. Travis, E.J. Holowaty, K. Bergfeldt, C.F. Lynch, B.A. Kohler, and T. Wiklund Risk of leukemia after platinum-based chemotherapy for ovarian cancer N Engl J Med 340 1999 351 357 (Pubitemid 29090800)
10. A. Kuendgen, and U. Germing Emerging treatment strategies for acute myeloid leukemia in the elderly Cancer Treat Rev 35 2 2009 97 120
11. W.P. McGuire, W.J. Hoskins, M.F. Brady, P.R. Kucera, E.E. Partridge, and K.Y. Look Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer Semin Oncol 23 5suppl. 12 1996 40 47 (Pubitemid 26391379)
12. V. Guillem, and M. Tormo Influence of DNA damage and repair upon the risk of treatment related leukemia Leuk Lymphoma 49 2 2008 204 217 (Pubitemid 351193913)
13. R.F. Ozols Paclitaxel/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer Semin Oncol 27 3 Suppl. 7 2000 3 7 (Pubitemid 30643845)
14. R. Beekman, and I.P. Touw G-CSF and its receptor in myeloid malignancy Blood 115 25 2010 5131 5136
15. D. Hershman, A.I. Neugut, J.S. Jacobson, J. Wang, W.Y. Tsai, and R. McBride Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony stimulating factors during breast cancer adjuvant chemotherapy J Natl Cancer Inst 99 3 2007 196 205